These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22816737)

  • 1. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
    Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
    PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 5. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
    Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
    J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
    Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
    Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
    Remstein ED; Law M; Mollejo M; Piris MA; Kurtin PJ; Dogan A
    Leukemia; 2008 Jun; 22(6):1268-72. PubMed ID: 17989713
    [No Abstract]   [Full Text] [Related]  

  • 8. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
    Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
    Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.
    Robledo C; García JL; Benito R; Flores T; Mollejo M; Martínez-Climent JÁ; García E; Gutiérrez NC; Piris MA; Hernández JM
    PLoS One; 2011; 6(9):e24939. PubMed ID: 21957467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
    Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
    Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.
    Gruszka-Westwood AM; Hamoudi R; Osborne L; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):57-69. PubMed ID: 12461750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
    Parry M; Rose-Zerilli MJ; Gibson J; Ennis S; Walewska R; Forster J; Parker H; Davis Z; Gardiner A; Collins A; Oscier DG; Strefford JC
    PLoS One; 2013; 8(12):e83244. PubMed ID: 24349473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
    Novara F; Arcaini L; Merli M; Passamonti F; Zibellini S; Rizzi S; Rattotti S; Rumi E; Pascutto C; Vetro A; Astori C; Boveri E; Lucioni M; Paulli M; Zuffardi O; Lazzarino M
    Hum Pathol; 2009 Nov; 40(11):1628-37. PubMed ID: 19647853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.
    Rosenquist R; Roos G; Erlanson M; Küppers R; Bräuninger A; Hansmann ML
    Eur J Haematol; 2004 Sep; 73(3):210-4. PubMed ID: 15287919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.
    Vega F; Cho-Vega JH; Lennon PA; Luthra MG; Bailey J; Breeden M; Jones D; Medeiros LJ; Luthra R
    Br J Haematol; 2008 Jun; 142(2):216-26. PubMed ID: 18492102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32.
    Boonstra R; Bosga-Bouwer A; van Imhoff GW; Krause V; Palmer M; Coupland RW; Dabbagh L; van den Berg E; van den Berg A; Poppema S
    Mod Pathol; 2003 Dec; 16(12):1210-7. PubMed ID: 14681321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.